Prestige Wealth Management Group
MBRX icon

Prestige Wealth Management Group’s Moleculin Biotech MBRX Stock Holding History

Prestige Wealth Management Group’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– – – 1021
2021
Q4 		– Hold
0
– – – 1032
2021
Q3 		– Hold
0
– – – 909
2021
Q2 		– Hold
0
– – – 898
2021
Q1 		– Hold
0
– – – 889
2020
Q4 		– Hold
0
– – – 862
2020
Q3 		– Hold
0
– – – 800
2020
Q2 		– Hold
0
– – – 802
2020
Q1 		– Hold
0
– – – 790
2019
Q4 		– Hold
0
– – – 539
2019
Q3 		– Hold
0
– – – 546
2019
Q2 		– Hold
0
– – – 475

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return